Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Depression 2Radiation Injuries 1Neoplasms 1Head and Neck Neoplasms 1Depressive Disorder, Major 1

Interventions

Therapeutics 3Psychiatric Rehabilitation 3Mindfulness-Based Cognitive Therapy 3Cognitive Behavioral Therapy 3Vortioxetine 2Metformin 2Early Intervention, Educational 2drospirenone 1Whole Body Imaging 1Standard of Care 1Single Person 1Referral and Consultation 1Radiosurgery 1Psilocybin 1Pharmacogenomic Testing 1Motion 1Modafinil 1Mirtazapine 1Microscopy, Interference 1Methylphenidate 1Methods 1Mental Status and Dementia Tests 1Meditation 1Medical Marijuana 1Massage 1Ketamine 1Interviews as Topic 1Ethinyl Estradiol 1Educational Status 1Coping Skills 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Depression × Vortioxetine × Clear all
NCT04818099 2021-03-26

Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3 Unknown
208 enrolled
Head & Neck

Depression, Head and Neck Neoplasms, Radiation Injuries

NCT04253678 2020-02-05

Vortioxetine for Cancer Patients With Depression: An Observational Study

University of Malaya

Unknown
140 enrolled

Depression, Depressive Disorder, Major, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡